cancer clinical trials for CTO Pediatric Trials (ONC)

9 CTO Pediatric Trials (ONC) clinical trials found. View a list of all cancer clinical trial types.

• A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

  Current Status: Open

  View links and contact information related to this clinical trial

• AHEP1531 - Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

  Current Status: Open

  View links and contact information related to this clinical trial

• Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

  Current Status: Open

  View links and contact information related to this clinical trial

• AALL1731 A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

  Current Status: Open

  View links and contact information related to this clinical trial

• AGCT1531. A Phase 3 study of active surveillance for low risk and a randomized trial of carboplatin vs.cisplatin for standard risk pediatric and adult patients with germ cell tumors.

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Acute Lymphoblastic Leukemia

  Current Status: Open

  View links and contact information related to this clinical trial

• AAML18P1. Stopping tyrosine kinase inhibitors (TKI) to assess treatment-free remission (TFR) in pediatric chronic myeloid leukemia - chronic phase (CML-CP)

  Current Status: Open

  View links and contact information related to this clinical trial

• ACNS1422. A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients

  Current Status: Open

  View links and contact information related to this clinical trial